Skip to content
London Reel Collective

The Zimbabwean Government Turns Down ‘Lopsided’ US Health Aid Deal Because of Information Concerns

Health aid illustration
The offered American financial assistance was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has turned down a significant American healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's insistence on confidential data.

This move was revealed following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesperson later clarified that the United States was demanding access to genetic material for research and profit but was unwilling to share the resulting advantages from future medical innovations.

"We will now turn to the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had furnished over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for continued talks to secure a agreement agreeable to both sides so the country's critical HIV treatment initiative can continue.

Wider Implications

This development comes after a comparable situation in neighbouring Kenya, where a court halted a related health funding agreement after concerns were filed about the security of Kenyans' health data.

Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).

USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to enhance openness and accountability.

According to reports, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.

Details of the Rejected Agreement

This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through American-funded initiatives," Tremont added.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that might result from that provided information," his statement read.

"Effectively, our country would supply the basic resources for medical research without any certainty that the end products would be available to our citizens should a future pandemic arise."

Sovereignty and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks already set up through the international organization.

Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential global health emergencies.

"This framework is intended to guarantee that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the capability to develop them."

These objections regarding the US deal "are not meant as anti-American sentiment," he added.

"We welcome ongoing discussions with our American counterparts on how future co-operation could be structured in a way that respects the independence and dignity of each country."

Health Experts Reaction

Medical experts expressed it understood the government's concerns, but urged that talks must proceed given that a large portion of the country's HIV programmes relied on international support.

"If technical issues arise, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group said.

The halted deal emphasises the complex debate between accepting much-needed international aid and protecting national sovereignty in an ever more data-driven world.

RB
The writer

Raymond Bowen

Award-winning filmmaker and curator passionate about urban narratives and community-driven cinema.

London Reel Collective

Type to search articles.